Charting the molecular network of the drug target Bcr-Abl

समान संसाधन

• The chemokine interleukin‐8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia
  द्वारा: Hantschel, Oliver, और अन्य
  प्रकाशित: (2008)
• The Growing Arsenal of ATP-Competitive and Allosteric Inhibitors of BCR–ABL
  द्वारा: Hantschel, Oliver, और अन्य
  प्रकाशित: (2012)
• The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib
  द्वारा: Hantschel, Oliver, और अन्य
  प्रकाशित: (2007)
• Initial characterization of the human central proteome
  द्वारा: Burkard, Thomas R, और अन्य
  प्रकाशित: (2011)
• A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
  द्वारा: Wojcik, John, और अन्य
  प्रकाशित: (2010)